Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
May 01, 2010 (Vol. 30, No. 9)

WHO/TDR Malaria Database

URL:www.wehi.edu.au/other_domains/MalDB/who.html
  • Great databases
  • Some of the pages (e.g., conferences) are outdated

Aren’t mosquito bites just the worst? No, I correct myself—contracting malaria from mosquito bites is the worst! Well, hey—don’t blame the mosquito. We should be focused on the parasite, Mr. Plasmodium falciparum. Many scientists are, in fact, entirely focused on Plasmodium falciparum, and the WHO/TDR Malaria Database is a wonderful online resource for malaria researchers. The site includes a malaria metabolism database, nucleotide and protein data files, and a malaria discussion group, among other resources. The WHO/TDR Malaria Database provides a number of tools that will undoubtedly help researchers move closer to putting an end to the pernicious Plasmodium once and for all! (Next up on the agenda: how to assuage that most annoying itching sensation.)

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »